Why the study?
Do circulating miRNA expression profiles differ between patients with acute new-onset atrial fibrillation, well-controlled atrial fibrillation, and normal sinus rhythm?
Do circulating miRNA expression profiles differ between patients with acute new-onset atrial fibrillation, well-controlled atrial fibrillation, and normal sinus rhythm?
Specific circulating miRNAs (miR-133b, miR-328, miR-499) are upregulated in acute new-onset atrial fibrillation, highlighting their potential role as biomarkers for early detection and monitoring.
No takes yet. Share an insight, caveat, or question.
May aid AF subtype differentiation in research settings; hypothesis-generating and should not yet change practice.
Silva et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: